References
- Gasser T. Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects. Prog. Brain Res.183, 3–20 (2010).
- Hamza TH, Zabetian CP, Tenesa A et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease. Nat. Genet.42, 781–785 (2010).
- Singleton AB, Hardy J, Traynor BJ, Houlden H. Towards a complete resolution of the genetic architecture of disease. Trends Genet.26, 438–442 (2010).
- Claassen DO, Josephs KA, Ahlskog JE et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology75, 494–499 (2010).
- Wong KK, Muller ML, Kuwabara H, Studenski SA, Bohnen NI. Olfactory loss and nigrostriatal dopaminergic denervation in the elderly. Neurosci. Lett.484, 163–167 (2010).
- Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging24, 197–211 (2003).
- Lee BD, Shin JH, VanKampen J, Petrucelli L, West AB, Ko HS. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson’s disease. Nat. Med.16, 998–1000 (2010).
- Politis M, Piccini P. Brain imaging after neural transplantation. Prog. Brain Res.184, 193–203 (2010).
- Magen I, Chesselet MF. Genetic mouse models of Parkinson’s disease: the state of the art. Prog. Brain Res.184, 53–87 (2010).